Amgen San News Today : Breaking News, Live Updates & Top Stories | Vimarsana

/PRNewswire/ (Oct. 6, 2022) – Amgen (NASDAQ:AMGN) today announced the opening of a new research and development site in San Francisco s Oyster Point,.

San francisco bayUnited statesPuerto ricoThousand oaksSan franciscoMichael strapazonSaptarsi haldarJessica akopyanRoberta bradwayKyowa kirin co ltdBeigene ltdExchange commissionTherapeutics incHuman rights campaignTeneobio incChemocentryx inc